1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
(
- Contribution to journal › Article
- 2023
-
Mark
Data quality and patient characteristics in European ANCA-associated vasculitis registries : data retrieval by federated querying
(
- Contribution to journal › Article
- 2022
-
Mark
Infection is associated with increased risk of MPO- but not PR3-ANCA associated vasculitis
(
- Contribution to journal › Article
- 2019
-
Mark
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term patient survival in a Swedish population-based cohort of patients with ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Immune response to pneumococcal conjugate vaccine in patients with systemic vasculitis receiving standard of care therapy
(
- Contribution to journal › Article
- 1998
-
Mark
Alpha-1-antitrypsin deficiency (PiZ): Clinical studies with special regard to hepatic and vasculitic disorders
1998)(
- Thesis › Doctoral thesis (monograph)
- 1994
-
Mark
Strong link between the alpha1‐antitrypsin PiZ allele and Wegener's granulomatosis
(
- Contribution to journal › Article
-
Mark
Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern
(
- Contribution to journal › Article
- 1993
-
Mark
Igg subclasses of antineutrophil cytoplasm autoantibodies (anca)
(
- Contribution to journal › Article